Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
SK Biopharmaceuticals Announces 100,000 Patients Globally Have Been Treated with Cenobamate Through Sales of XCOPRI® and ONTOZRY® in the U.S., Europe, Israel, and Canada 2024-03-12 08:00
SK Life Science Labs, a Subsidiary of SK Biopharmaceuticals, Presents Discovery of Oral SMARCA2 Degraders Data at 6th Annual Targeted Protein Degradation Summit 2023-10-31 08:00
SK Biopharmaceuticals' Proteovant Therapeutics Presents Preclinical Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023-10-13 09:00
SK Biopharmaceuticals' Proteovant Therapeutics Presents Preclinical Data on IKZF2 Protein Degrader Program and MOPED™ Molecular Glue Screening Platform at the 20th Annual Discovery on Target Conference 2023-09-27 08:30
SK Biopharmaceuticals Assembles 'Board of Prominent Experts' to Boost Growth, Innovation 2023-08-03 07:30
SK Biopharmaceuticals Makes Big Bets to be 'Big Biotech' 2023-07-18 09:00
SK Biopharmaceuticals Wins Red Dot Design Award for Wearable Devices 2023-04-11 08:00
SK Biopharmaceuticals to Present Future Plan for Global Investors, Partners at 'SK Bio Night' 2023-01-10 07:00
SK Biopharmaceuticals CEO Donghoon Lee Buys 3,000 Shares of Company Stock 2023-01-06 09:10
SK Biopharmaceuticals Unveils Vision for Digital Healthcare 2022-12-14 10:00
SK Biopharmaceuticals' Partner Angelini Pharma Launches Cenobamate in France 2022-12-09 06:30
SK Biopharmaceuticals Wins Export Award for Cenobamate 2022-12-06 08:00
Seoul National University Bundang Hospital Presents Study of SK Biopharmaceuticals' Seizure Detection Wearable Device at AES 2022 2022-12-05 08:00
SK Biopharmaceuticals Names Donghoon Lee, Head of Bio Investment Center of SK Inc., as New CEO 2022-12-01 09:30
SK Biopharmaceuticals Named CES 2023 Innovation Awards Honoree 2022-11-17 07:09
SK Biopharmaceuticals Receives Korea Drug Development Fund Investment Grant to Develop Novel Oncology Candidate, SKL27969 2022-11-14 08:00
1